A community-based model of care improves blood pressure control and delays progression of proteinuria, left ventricular hypertrophy and diastolic dysfunction in Maori and Pacific patients with type 2 diabetes and chronic kidney disease: A randomized controlled trial

Nephrology Dialysis Transplantation

Volumn 25, Issue 10, 2010, Pages 3260-3266

  Hotu, Cheri ^a   Bagg, Warwick ^a   Collins, John ^b   Harwood, Lorraine ^a   Whalley, Gillian ^a   Doughty, Robert ^a   Gamble, Greg ^a   Braatvedt, Geoffrey ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

community care; diabetes; hypertension; nephropathy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MALE; MAORI; NON INSULIN DEPENDENT DIABETES MELLITUS; PACIFIC ISLANDER; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AGED; CHRONIC DISEASE; COMMUNITY HEALTH SERVICES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIASTOLE; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; MALE; MIDDLE AGED; PROTEINURIA;

EID: 77957242465     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq168     Document Type: Article

References (25)

1. Stewart JH, McCredie MR, McDonald SP. The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in indigenous Australians. Nephrol Dial Transplant 2004; 19: 678-685
2. Levey AS, Beto JA, Coronado BE et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Taskforce on Cardiovascular Disease. Am J Kidney Dis 1998; 32: 853-906
3. McDonald SP, Russ GR. Current incidence, treatment patterns and incidence of end-stage renal disease among indigenous groups in Australia and New Zealand. Nephrology 2003; 8: 42-48
4. Bakris GL, Weir MR, Shanifar S et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med 2003; 163: 1555-1565
5. Devereux RB, Roman MJ, Paranicas M et al. Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation 2000; 101: 2271-2276
6. Hildebrandt P, Wachtell K, Dahlöf§ P et al. Impairment of cardiac function in hypertensive patients with type 2 diabetes: a LIFE study. Diabet Med 2005; 22: 1005-1011
7. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New Engl J Med 1990; 322: 1561-1566
8. Wang M, Yip GW, Wang AY et al. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hypertension 2005; 23: 183-191
9. Whalley GA, Gamble GD, Doughty RN. The prognostic significance of restrictive diastolic filling associated with heart failure: a meta-analysis. Int J Cardiol 2007; 116: 70-77
10. Hillege HL, Nitsch D, Pfeffer MA et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113: 671-678
11. Gerstein HC, Mann JFE, Yi Q et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426
12. Brenner BM, Cooper M, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New Engl J Med 2001; 345: 861-869
13. De Nicola L, Minutolo R, Bellizzi V et al. Achievement of target blood pressure levels in chronic kidney disease: a salty question? Am J Kidney Dis 2004; 43: 782-795
14. Denver EA, Barnard M, Woolfson RG, Earle KA. Management of uncontrolled hypertension in a nurse-led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care 2003; 26: 2256-2260
15. Logan AG, Milne BJ, Achber C, Campbell WP, Haynes RB. Worksite treated hypertension by specially trained nurses. Lancet 1979; 2: 1175-1178
16. Hill MN, Hae-Ra H, Dennison CR et al. Hypertension care and control in underserved urban African American men: behavioural and physiologic outcomes at 36 months. Am J Hypertens 2003; 16: 906-913
17. Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification: a report from the American Society of Echocardio-graphy's Guidelines and Standards Committee, and the Chamber, Quantification Writing Group, Developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463
18. A Portrait of Health: New Zealand Health Survey 2006/2007. New Zealand Ministry of Health. http://www.moh.govt.nz/moh.nsf/pagesmh/7601/$File/ diabetes-ch3.pdf
19. Simmons D, Shaw LM, Scott DJ, Kenealy T, Scragg KK. Diabetic nephropathy and microalbuminuria in the community. The South Auckland Diabetes Survey. Diabetes Care 1994; 17: 1404-1410
20. Hovind P, Rossing P, Tarnow L, Smidt U, Parving HH. Progression of diabetic nephropathy. Kidney Int 2001; 59: 702-709
21. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004; 291: 335-342
22. Tomlin A, Tilyard M, Dawson A, Dovey S. Health status of New Zealand European, Maori, and Pacific patients with diabetes in 242 New Zealand general practices. NZ Med J 119ISSN 1175 8716, 2006
23. Robinson T, Simmons D, Scott D et al. Ethnic differences in type 2 diabetes care and outcomes in Auckland, a multiethnic community in New Zealand. NZ Med J 119; ISSN 1175 8716. 2006
24. Simmons D, Weblemoe T, Voyle J, Prichard A, Leakehe L, Gatland B. Personal barriers to diabetes care: lessons from a multiethnic community in New Zealand. Diabet Med 1998; 15: 958-964
25. Oliveira SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz D, RAsch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002; 162: 413-420